Claims
- 1. A compound of the formula ##STR110## wherein n is a whole number from 2 to 8 and up to 4 hydrogen atoms in the alkylene chain (CH.sub.2).sub.n may be replaced by alkyl of from 1 to 3 carbon atoms;
- R, R.sup.1, R.sup.2 and R.sup.3 are hydrogen or alkyl of from 1 to 8 carbon atoms, aralkyl wherein alkyl is 1 to 3 carbon atoms, cycloalkyl or from 3 to 7 carbon atoms in the ring, cycloalkylmethyl with from 3 to 7 carbon atoms in the ring, alkoxyalkyl wherein alkoxy is 1 to 4 carbon atoms and alkyl is 1 to 4 carbon atoms, lower alkylcarbonyloxyalkyl, hydroxyalkyl of from 1 to 4 carbon atoms, haloalkyl of from 1 to 3 carbon atoms, ##STR111## wherein m is 0, 2 or 3 and R.sup.4 and R.sup.5 are the same or different and are
- hydrogen or alkyl of from 1 to 4 carbon atoms; phenyl, substituted phenyl wherein the substituent is alkyl of from 1 to 3 carbon atoms, alkoxy of from 1 to 3 carbon atoms, halogen or haloalkyl of from 1 to 3 carbon atoms;
- the Y substituents are the same or different and are hydrogen, alkyl of from 1 to 4 carbon atoms, hydroxyalkyl of from 1 to 4 carbon atoms, deuteroalkyl of from 1 to 4 carbon atoms, phenyl, hydroxy, halogen, ##STR112## wherein m is 0-3 and R.sup.7 and R.sup.8 are the same or different and are hydrogen, alkyl of from 1 to 4 carbon atoms or aralkyl wherein alkyl is 1 to 3 carbon atoms; haloalkyl of from 1 to 4 carbon atoms, alkoxy of from 1 to 4 carbon atoms, aralkoxy wherein alkoxy is 1 to 3 carbon atoms, alkylthio of from 1 to 4 carbon atoms, alkylsulfonyl of 1 to 4 carbon atoms, cyano, nitro, formyl, loweralkoxycarbonoyl wherein alkoxy is 1 to 5 carbon atoms or carbamoyl;
- X is oxygen or sulfur;
- and the quaternary ammonium or N-oxide derivatives thereof, and the pharmaceutically acceptable acid-addition salts thereof.
- 2. A compound according to claim 1 of the formula ##STR113## wherein n, R, R.sup.1, R.sup.2 and R.sup.3 have the same meaning as in claim 1 and Y.sup.1 is hydrogen, alkyl of from 1 to 4 carbon atoms, alkoxy of 1 to 4 carbon atoms, haloalkyl of 1 to 3 carbon atoms, hydroxyalkyl of 1 to 4 carbon atoms, deuteroalkyl of 1 to 4 carbon atoms or alkylthio of 1 to 4 carbon atoms; Y.sup.2 is hydrogen, alkyl of 1 to 4 carbon atoms or halogen, and Y.sup.3 is hydrogen, alkyl of from 1 to 4 carbon atoms, hydroxyalkyl of 1 to 4 carbon atoms, deuteroalkyl of 1 to 4 carbon atoms, haloalkyl of 1 to 3 carbon atoms, amino, methylamino, dimethylamino or halogen.
- 3. A compound according to claim 2 of the formula ##STR114## wherein Y.sup.1, Y.sup.2, Y.sup.3, m, R, R.sup.1, R.sup.2 and R.sup.3 have the same meaning as in claim 2.
- 4. A compound according to claim 3 wherein Y.sup.1 is H, methyl or CF.sub.3, Y.sup.2 is H or chloro, and Y.sup.3 is H, methyl, chloro, CH.sub.3, amino, methylamino or dimethylamino.
- 5. A compound according to claim 3 of the formula ##STR115##
- 6. A compound of claim 5 wherein Y.sup.1 is CH.sub.3 and Y.sup.2 and Y.sup.3 each is H.
- 7. A compound of claim 5 wherein Y.sup.1 and Y.sup.3 each is CH.sub.3 and Y.sup.2 is H.
- 8. A compound of claim 5 wherein Y.sup.1 is CH.sub.3, Y.sup.2 is H and Y.sup.3 is Cl.
- 9. A compound of claim 5 wherein Y.sup.1 is CF.sub.3, Y.sup.2 is H and Y.sup.3 is CH.sub.3.
- 10. A compound of claim 5 wherein Y.sup.1 and Y.sup.3 each is H and Y.sup.2 is Cl.
- 11. A compound of claim 5 wherein Y.sup.1 and Y.sup.3 each is CH.sub.3 and Y.sup.2 is Cl.
- 12. A compound of claim 5 wherein Y.sup.1 and Y.sup.2 each is H and Y.sup.3 is Cl.
- 13. A compound of claim 5 wherein Y.sup.1 and Y.sup.2 each is H and Y.sup.3 is CF.sub.3.
- 14. A compound of claim 5 wherein Y.sup.1 and Y.sup.2 each is H and Y.sup.3 is amino.
- 15. A compound of claim 5 wherein Y.sup.1 is C.sub.2 H.sub.5 and Y.sup.2 and Y.sup.3 are H.
- 16. A compound of claim 5 wherein Y.sup.1 is --OCH.sub.3 and Y.sup.2 and Y.sup.3 are H.
- 17. A compound of claim 5 wherein Y.sup.1 is CF.sub.3 and Y.sup.2 and Y.sup.3 are H.
- 18. A compound of claim 5 wherein Y.sup.1 is CH.sub.3, Y.sup.2 is H and Y.sup.3 is --CHF.sub.2.
- 19. A compound of claim 5 wherein Y.sup.1 and Y.sup.2 are H and Y.sup.3 is CH.sub.3.
- 20. A compound of claim 5 wherein Y.sup.1 is CH.sub.3, Y.sup.2 is H and Y.sup.3 is --CH.sub.2 OH.
- 21. A compound of claim 5 wherein Y.sup.1 is CH.sub.2 OH, Y.sup.2 is H and Y.sup.3 is CH.sub.3.
- 22. A compound of claim 5 wherein Y.sup.1 and Y.sup.3 are --CD.sub.3 an Y.sup.2 is H.
- 23. A compound of claim 5 wherein Y.sup.1 is CF.sub.3, Y.sup.2 is H and Y.sup.3 is --NHCH.sub.3.
- 24. A compound of claim 5 wherein Y.sup.1 is --SCH.sub.3 and Y.sup.2 and Y.sup.3 are H.
- 25. A compound of claim 3 wherein R is cyclopropyl, R.sup.1 is isopropyl, R.sup.2 and R.sup.3 are CH.sub.3, m is 2, Y.sup.1 and Y.sup.3 are CH.sub.3 and Y.sup.2 is H.
- 26. A compound of claim 3 wherein R and R.sup.1 are isopropyl, R.sup.2 and R.sup.3 are --CH.sub.2 CH.sub.2 OH, m is 2, Y.sup.1 and Y.sup.3 are CH.sub.3 and Y.sup.2 is H.
- 27. A compound of claim 2 which is N,N-dimethyl-N'-(6-diisopropylaminohexyl)-N'-(5-methyl-3-pyridyl)urea.
- 28. A method for inhibiting gastric acid secretion which comprises administering to a mammalian species an effective amount of a compound of claim 1.
- 29. A method according to claim 28 wherein the compound is administered at a dose level of from about 10 to about 200 mg.kg.
- 30. A composition comprising an effective amount of a compound of claim 1 in combination with a pharmaceutically acceptable carrier.
CROSS REFERENCE TO RELATED APPLICATIONS
This application is a continuation-in-part of application Ser. No. 727,907, filed Sept. 29, 1976, now abandoned, which is a continuation-in-part of application Ser. No. 631,300, filed Nov. 12, 1975, now abandoned.
US Referenced Citations (8)
Foreign Referenced Citations (3)
Number |
Date |
Country |
819436 |
Feb 1975 |
BEX |
834247 |
Feb 1976 |
BEX |
1267433 |
Mar 1972 |
GBX |
Non-Patent Literature Citations (2)
Entry |
Burger, Medicinal Chemistry, 2nd Edition (1960), p. 497. |
Burger, Medicinal Chemistry, 3rd Edition (1970), p. 1588. |
Continuation in Parts (2)
|
Number |
Date |
Country |
Parent |
727907 |
Sep 1976 |
|
Parent |
631300 |
Nov 1975 |
|